Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

J. Barlin · SciRah

Researcher profile · Semantic Scholar

J. Barlin

Share profile

J. Barlin — researcher profile on SciRah

h-index: 14
Works: 53
Citations: 1,778

Most-cited papers

The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes.
J. Barlin, F. Khoury-Collado, Christine H. Kim, M. Leitao +6 more
2012Gynecologic Oncology409 citations
Semantic Scholar
A Randomized, Phase III Trial to Evaluate Rucaparib Monotherapy as Maintenance Treatment in Patients With Newly Diagnosed Ovarian Cancer (ATHENA–MONO/GOG-3020/ENGOT-ov45)
Bradley J. Monk, C. Parkinson, M. Lim, D. O'Malley +35 more
2022Journal of Clinical Oncology346 citations Open access
Semantic Scholar
Pathologic Ultrastaging Improves Micrometastasis Detection in Sentinel Lymph Nodes during Endometrial Cancer Staging
Christine H. Kim, R. Soslow, Kay J. Park, E. Barber +6 more
2013International Journal of Gynecologic Cancer265 citations Open access
Semantic Scholar
Cytoreductive surgery for advanced or recurrent endometrial cancer: a meta-analysis.
J. Barlin, Isha Puri, R. Bristow
2010Gynecologic Oncology192 citations
Semantic Scholar
Classification and Regression Tree (CART) Analysis of Endometrial Carcinoma: Seeing the Forest for the Trees
J. Barlin, Qin C. Zhou, C. S. St Clair, A. Iasonos +6 more
2013Gynecologic Oncology96 citations Open access
Semantic Scholar
Nomogram for predicting 5-year disease-specific mortality after primary surgery for epithelial ovarian cancer.
J. Barlin, Chang-Hong Yu, E. Hill, O. Zivanovic +8 more
2012Gynecologic Oncology66 citations
Semantic Scholar
Disparity between resident and attending physician perceptions of intraoperative supervision and education.
K. Levinson, J. Barlin, K. Altman, A. Satin
2010Journal of Graduate Medical Education55 citations Open access
Semantic Scholar
Follow-Up Study of the Correlation Between Postoperative Computed Tomographic Scan and Primary Surgeon Assessment in Patients With Advanced Ovarian, Tubal, or Peritoneal Carcinoma Reported to Have Undergone Primary Surgical Cytoreduction to Residual Disease of 1 cm or Smaller
D. Chi, J. Barlin, P. Ramirez, C. Levenback +6 more
2009International Journal of Gynecologic Cancer54 citations Open access
Semantic Scholar
Validated gene targets associated with curatively treated advanced serous ovarian carcinoma.
J. Barlin, P. Jelinic, Narciso Olvera, F. Bogomolniy +5 more
2012Gynecologic Oncology52 citations
Semantic Scholar
Redefining Stage I Endometrial Cancer: Incorporating Histology, a Binary Grading System, Myometrial Invasion, and Lymph Node Assessment
J. Barlin, R. Soslow, M. Lutz, Qin C. Zhou +7 more
2013International Journal of Gynecologic Cancer51 citations Open access
Semantic Scholar
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in ovarian, fallopian tube, and primary peritoneal cancer.
J. Barlin, F. Dao, N. Zgheib, S. Ferguson +7 more
2012Gynecologic Oncology46 citations
Semantic Scholar
Molecular Subtypes of Uterine Leiomyosarcoma and Correlation with Clinical Outcome
J. Barlin, Qin C. Zhou, M. Leitao, Maria Bisogna +10 more
2015Neoplasia45 citations Open access
Semantic Scholar
ARTISTRY-7: Phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer.
T. Herzog, J. Hays, J. Barlin, J. Buscema +18 more
2023Future Oncology16 citations Open access
Semantic Scholar
Location of Disease in Patients Who Die From Endometrial Cancer: A Study of 414 Patients From a Single Institution
J. Barlin, W. Wysham, A. Ferda, F. Khoury-Collado +6 more
2012International Journal of Gynecologic Cancer16 citations Open access
Semantic Scholar
Cytoreductive Surgery for Advanced and Recurrent Endometrial Cancer: a Review of the Literature
J. Barlin, S. Ueda, R. Bristow
2009Women's Health13 citations Open access
Semantic Scholar
A comparison of primary intraperitoneal chemotherapy to consolidation intraperitoneal chemotherapy in optimally resected advanced ovarian cancer.
Rudy S. Suidan, C. S. St Clair, Stephen J. Lee, J. Barlin +6 more
2014Gynecologic Oncology9 citations
Semantic Scholar
527MO Rucaparib maintenance treatment in patients (pts) with newly diagnosed ovarian cancer (OC): Defining benefit according to disease risk subgroups within the phase 3 ATHENA–MONO study
K. Fujiwara, R. Kristeleit, S. Ghamande, M. Lim +16 more
2022Annals of Oncology6 citations Open access
Semantic Scholar
Computed tomographic peritoneography prior to intraperitoneal chemotherapy in advanced Müllerian cancer: a pilot study.
J. Barlin, R. Bristow, K. Bleich, R. Giuntoli +2 more
2010Clinical imaging5 citations
Semantic Scholar
ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68).
T. Herzog, J. Hays, J. Barlin, J. Buscema +16 more
2023Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Recurrent cervical cancer isolated to the sigmoid colon: A case report
J. Barlin, Josephine S. Kim, R. Barakat
2013Gynecologic Oncology Case Reports4 citations Open access
Semantic Scholar
Surgical Approaches and Short-Term Surgical Outcomes for Patients with Morbid Obesity and Endometrial Cancer
R. Salani, M. Gerardi, J. Barlin, E. Veras +1 more
20094 citations
Semantic Scholar
Management of uterine leiomyosarcoma: an update
J. Barlin, R. Giuntoli
20094 citations
Semantic Scholar
Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin is comparable to results from GOG 172
J. Barlin, F. Dao, N. Zgheib, S. Ferguson +6 more
20123 citations
Semantic Scholar
FLORA-5/GOG3035: Frontline chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO] versus chemotherapy (paclitaxel-carboplatin-placebo [PCP]) in patients with advanced epithelial ovarian cancer (EOC)—Phase III, double-blind, placebo-controlled, global, multinational study.
A. Secord, L. Barroilhet, M. Lim, S. Gupta +13 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients (pts) with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer.
T. Herzog, K. Moore, P. Konstantinopoulos, L. Gilbert +11 more
2022Journal of Clinical Oncology2 citations
Semantic Scholar
Unraveling the cause of death in endometrial cancer: A study of 2513 patients from a single institution
J. Barlin, W. Wysham, A. Ferda, F. Collado +6 more
20122 citations
Semantic Scholar
The evolving pathogenesis model of high-grade pelvic serous carcinoma.
J. Barlin, D. Levine
2011Gynecologic Oncology2 citations
Semantic Scholar
Role of secondary cytoreduction in recurrent ovarian cancer
J. Barlin, R. Bristow, D. Chi
20102 citations
Semantic Scholar
462 Progression-free survival 2-progression-free survival 1 in patients with primary advanced/recurrent endometrial cancer treated with dostarlimab plus chemotherapy compared with chemotherapy alone in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
C. Mccourt, G. Ronzino, M. Shahin, R. Kristeleit +16 more
2024Oral Sessions1 citations Open access
Semantic Scholar
FLORA-5/GOG3035: Chemo-immunotherapy (paclitaxel-carboplatin-oregovomab [PCO] vs chemotherapy (paclitaxel-carboplatin-placebo [PCP]) as front-line treatment in patients with advanced epithelial ovarian cancer (EOC)—Phase III, double blind, placebo controlled, global, multinational study.
L. Barroilhet, M. Lim, Sunil Gupta, S. Jada +10 more
2023Journal of Clinical Oncology1 citations Open access
Semantic Scholar
TP025/#1399 Artistry-7: phase 3 multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer
T. Herzog, J. Hays, K. Moore, P. Konstantinopoulos +10 more
2022E-Posters (Trials In Progress)1 citations Open access
Semantic Scholar
Redefining stage I endometrial cancer: Incorporating histology, grade, myoinvasion, and whether or not lymph nodes were removed
J. Barlin, M. Lutz, Qin C. Zhou, C. S. St Clair +6 more
20131 citations
Semantic Scholar
Does postmenopausal risk-reducing salpingo-oophorectomy reduce the risk of BRCA-associated breast cancer?
J. Barlin, M. Pike, E. Otegbeye, A. Arnold +6 more
20131 citations
Semantic Scholar
Incidence of sentinel lymph node metastasis in endometrial carcinoma: Correlation with tumor grade and myometrial invasion
F. Collado, O. Alchyib, C. Kim, J. Barlin +6 more
20121 citations Open access
Semantic Scholar
Nanometastases of Endometrial Carcinoma to Sentinel Lymph Nodes: The Contribution of Pathologic Ultrastaging
C. Kim, F. Khoury-Collado, J. Barlin, Kay J. Park +6 more
20121 citations
Semantic Scholar
Response to: “What is the role of neoadjuvant chemotherapy in advanced endometrial cancer?”
J. Barlin, R. Bristow
20101 citations
Semantic Scholar
Predictive value of endocervical curettage at cervical conization and provider practices in management of high-grade cervical dysplasia.
J. Barlin, R. Bristow, Anna M Murillo, M. Zahurak +2 more
2010Journal of reproductive medicine1 citations
Semantic Scholar
#487 ARTISTRY-7: a phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)
J. Sehouli, John L Hays, J. Barlin, J. Buscema +16 more
2023Poster/ePoster Sessions0 citations Open access
Semantic Scholar
TP011/#1536 A double-blind placebo-controlled phase III chemo-immunotherapy (Paclitaxel-carboplatin-oregovomab [PCO]) vs chemotherapy (Paclitaxel-carboplatin-placebo [PCP]) in patients with newly diagnosed, advanced epithelial ovarian cancer (EOC): FLORA-5/GOG-3035 study
M. Lim, Yong-Man Kim, Sunil Gupta, S. Jada +10 more
2023ePoster Viewing: Trials-in-Progress0 citations Open access
Semantic Scholar
ARTISTRY-7: A phase 3, multicenter study of nemvaleukin alfa in combination with pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (1307)
T. Herzog, John L Hays, J. Barlin, J. Buscema +18 more
2023Gynecologic Oncology0 citations
Semantic Scholar
2022-RA-687-ESGO ARTISTRY-7: phase 3, multicenter study of nemvaleukin alfa plus pembrolizumab versus chemotherapy in patients with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer (GOG-3063; ENGOT-OV68)
T. Herzog, K. Moore, P. Konstantinopoulos, L. Gilbert +11 more
2022Ovarian cancer0 citations Open access
Semantic Scholar
FLORA-5: A phase III double blind placebo controlled multicenter clinical study of front-line chemo-immunotherapy (paclitaxel and carboplatin +/- oregovomab) in patients with advanced epithelial ovarian cancer (GOG-3035) (298)
A. Secord, L. Barroilhet, S. Gupta, S. Oosman +11 more
2022Gynecologic Oncology0 citations
Semantic Scholar
TP021/#1521 FLORA-5/GOG3035: chemo-immunotherapy (paclitaxel and carboplatin ± oregovomab) as front-line treatment for patients with ovarian cancer. A phase III double blind placebo controlled, global multicenter study
Angeles Alvarez Secord, L. Barroilhet, Myong Cheol Lim, S. Oosman +11 more
2022E-Posters (Trials In Progress)0 citations Open access
Semantic Scholar
Novel sandwich therapy protocol supports role for concurrent chemoradiation in endometrial cancer
D.-J. Wen, H. Godoy, L. M. Armao, J. Barlin +3 more
20150 citations
Semantic Scholar
Passage of Medicare mandate fails to shorten time to BRCA testing in ovarian cancer patients
O. Filippova, P. Feustel, L. M. Armao, J. Barlin +4 more
20150 citations
Semantic Scholar
Presentation and treatment of leiomyosarcoma: An eight-year experience at a single community-based gynecologic oncology practice
O. Filippova, P. Feustel, H. Godoy, Timothy J. McElrath +3 more
20150 citations
Semantic Scholar
Breast cancer risk with hormone replacement after risk-reducing salpingo-oophorectomy in BRCA mutation carriers: Does it abrogate the benefit?
J. Barlin, A. Arnold, S. Mobley, E. Otegbeye +5 more
20140 citations
Semantic Scholar
External validation of an all-stage ovarian cancer nomogram: Is BRCA status more predictive than family history?
B. Cormier, J. Barlin, O. Charette, L. Kou +4 more
20140 citations
Semantic Scholar
Uterine leiomyosarcomas have reproducible molecular subtypes that correlate with survival
J. Barlin, Qin C. Zhou, M. Leitao, Maria Bisogna +6 more
20130 citations
Semantic Scholar
Does para-aortic lymph node assessment during endometrial cancer staging impact overall survival?
J. Barlin, Qin Zhou, C. S. St Clair, A. Iasonos +6 more
20130 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

R. Barakat×17
Invite
R. Barakat — researcher profile on SciRah
D. Chi×14
Invite
D. Chi — researcher profile on SciRah
N. Abu-Rustum×11
Invite
N. Abu-Rustum — researcher profile on SciRah
M. Hensley×10
Invite
M. Hensley — researcher profile on SciRah

×9

Invite

D. O'Malley — researcher profile on SciRah

Invite

M. Leitao — researcher profile on SciRah

Invite

L. Gilbert — researcher profile on SciRah

Invite

B. Monk — researcher profile on SciRah

Invite

R. Bristow — researcher profile on SciRah

Invite

Y. Sonoda — researcher profile on SciRah

D. Provencher×6

Invite

D. Provencher — researcher profile on SciRah

Invite

T. Herzog — researcher profile on SciRah